Increased risk of infection such as upper respiratory tract infection (URTI), urinary tract infection (UTI) and skin infections. If you get an infection while on biologic or biosimilar, inform your healthcare professional so it can be treated immediately.
Reactivation of certain infectious diseases such as Hepatitis B or Tuberculosis (TB). Your doctor will order tests to assess your risk and decide on treatment before starting a biologic or biosimilar. In addition, your doctor will ensure your vaccination status is updated to further reduce your risk of getting an infection.
Common > 10%
Infection such as cold, upper respiratory infection, sinusitis, mild injection site reactions such as redness and pain
Uncommon 1-3%
Severe infection require hospitalisation, severe infusion reactions.
Central nervous system reaction such as sudden vision problems or any numbness or tingling.
Cardiac (heart) issues which may manifest as shortness of breath or sudden swelling of the ankles.
Rare < 1 in 1000
Reactivation of Tuberculosis (TB), Shingles, Hepatitis B, cancer of the blood, skin or lung, another immune diseases such as lupus-like syndrome (which may appear as rash that gets worse when exposed to the sun or new joint pains)
Inform your healthcare professional immediately if you experience any of these or other unexplained symptoms.
Subscribe to our mailing list to get the updates to your email inbox...
